FindTrial
Sign In

Risk factors for postoperative severe morbidity after pheochromocytoma surgery

Risk factors for postoperative severe morbidity after pheochromocytoma surgery

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800017893
Enrollment
Unknown
Registered
2018-08-20
Start date
2018-08-17
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pheochromocytoma

Interventions

patients with morbidity:adrenalectomy
patients without morbidity:adrenalectomy

Sponsors

ShengJing Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The diagnosis of pheochromocytoma was confirmed by pathologic examination and patients who underwent unilateral laparoscopic or open adrenalectomy were included. Clinical stage was localized (apparently benign) disease and American Society of Anesthesiologists (ASA) score was 1–3.

Exclusion criteria

Exclusion criteria: Patients converted to laparotomy and those who underwent bilateral adrenalectomy or surgery for ectopic pheochromocytoma were excluded.

Design outcomes

Primary

MeasureTime frame
Clavien-Dindo classification;—

Countries

China

Contacts

Public ContactSong Bai

Department of Urology, ShengJing Hospital of China Medical University

baisongcmu@163.com+86 18940255568

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026